Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Апрель 22, 2024
Introduction:
Although
post-COVID-19
syndrome
(PCS)
with
cognitive
impairment
is
increasingly
encountered
in
primary
care,
evidence-based
recommendations
for
its
appropriate
management
are
lacking.
Methods:
A
systematic
literature
search
evaluating
the
diagnosis
and
treatment
of
associated
PCS
was
conducted.
Practical
PCS-associated
care
summarized,
based
on
an
evaluation
pharmacological
plausibility
clinical
applications.
Results:
Currently,
pathology
remains
unclear
no
high-quality
data
to
support
targeted
interventions.
Existing
approaches
directed
towards
symptom
relief
where
counseling
chronicity
disease
regular
reassessments
at
4-
8-week
intervals
considered
reasonable.
Patients
should
be
informed
encouraged
adopt
a
healthy
lifestyle
that
centers
around
balanced
nutrition
physical
activities.
They
may
also
benefit
from
intake
vitamins,
micronutrients,
probiotics.
The
administration
Ginkgo
biloba
extract
could
offer
safe
potentially
beneficial
option.
Other
non-pharmacological
measures
include
physiotherapy,
digitally
supported
training,
and,
if
indicated,
ergotherapy
or
speech
therapy.
In
most
patients,
symptoms
improve
within
8
weeks.
If
serious,
ambiguous,
when
new
occur,
specialized
diagnostic
such
as
comprehensive
neurocognitive
testing
neuroimaging
initiated.
Very
few
patients
would
require
inpatient
rehabilitation.
Conclusion:
debilitating
condition
affect
daily
functioning
reduce
work
productivity.
Management
multidisciplinary
approach,
centering
physical,
cognitive,
therapies.
Experimental Physiology,
Год журнала:
2022,
Номер
108(1), С. 12 - 27
Опубликована: Ноя. 22, 2022
Abstract
Long
COVID,
the
prolonged
illness
and
fatigue
suffered
by
a
small
proportion
of
those
infected
with
SARS‐CoV‐2,
is
placing
an
increasing
burden
on
individuals
society.
A
Physiological
Society
virtual
meeting
in
February
2022
brought
clinicians
researchers
together
to
discuss
current
understanding
long
COVID
mechanisms,
risk
factors
recovery.
This
review
highlights
themes
arising
from
that
meeting.
It
considers
nature
exploring
its
links
other
post‐viral
illnesses
such
as
myalgic
encephalomyelitis/chronic
syndrome,
how
research
can
help
us
better
support
suffering
all
syndromes.
started
particularly
swiftly
populations
routinely
monitoring
their
physical
performance
–
namely
military
elite
athletes.
The
high
degree
diagnosis,
intervention
success
these
active
suggest
management
strategies
for
wider
population.
We
then
consider
key
component
populations,
cardiopulmonary
exercise
training,
has
revealed
COVID‐related
changes
physiology
including
alterations
peripheral
muscle
function,
ventilatory
inefficiency
autonomic
dysfunction.
impact
dysautonomia
are
further
discussed
relation
postural
orthostatic
tachycardia
treatment
aim
combat
sympathetic
overactivation
stimulating
vagus
nerve.
interrogate
mechanisms
underlie
symptoms,
focus
impaired
oxygen
delivery
due
micro‐clotting
disruption
cellular
energy
metabolism,
before
considering
indirectly
or
directly
tackle
mechanisms.
These
include
remote
inspiratory
training
integrated
care
pathways
combine
rehabilitation
drug
interventions
into
healthcare
access
across
different
populations.
Overall,
this
showcases
physiological
reveals
occur
therapeutic
being
developed
tested
condition.
Frontiers in Medicine,
Год журнала:
2023,
Номер
10
Опубликована: Март 31, 2023
The
Long
COVID/Post
Acute
Sequelae
of
COVID-19
(PASC)
group
includes
patients
with
initial
mild-to-moderate
symptoms
during
the
acute
phase
illness,
in
whom
recovery
is
prolonged,
or
new
are
developed
over
months.
Here,
we
propose
a
description
pathophysiology
COVID
presentation
based
on
inflammatory
cytokine
cascades
and
p38
MAP
kinase
signaling
pathways
that
regulate
production.
In
this
model,
SARS-CoV-2
viral
infection
hypothesized
to
trigger
dysregulated
peripheral
immune
system
activation
subsequent
release.
Chronic
low-grade
inflammation
leads
brain
microglia
an
exaggerated
release
central
cytokines,
producing
neuroinflammation.
Immunothrombosis
linked
chronic
microclot
formation
decreased
tissue
perfusion
ischemia.
Intermittent
fatigue,
Post
Exertional
Malaise
(PEM),
CNS
"brain
fog,"
arthralgias,
paresthesias,
dysautonomia,
GI
ophthalmic
problems
can
consequently
arise
as
result
elevated
cytokines.
There
abundant
similarities
between
myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS).
DNA
polymorphisms
viral-induced
epigenetic
changes
gene
expression
may
lead
patients,
predisposing
some
develop
autoimmunity,
which
be
gateway
ME/CFS.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(2), С. 753 - 753
Опубликована: Янв. 6, 2024
Aging
induces
numerous
physiological
alterations,
with
immunosenescence
emerging
as
a
pivotal
factor.
This
phenomenon
has
attracted
both
researchers
and
clinicians,
prompting
profound
questions
about
its
implications
for
health
disease.
Among
the
contributing
factors,
one
intriguing
actor
in
this
complex
interplay
is
human
cytomegalovirus
(CMV),
member
of
herpesvirus
family.
Latent
CMV
infection
exerts
influence
on
aging
immune
system,
potentially
to
age-related
diseases.
review
delves
into
intricate
relationship
between
CMV,
revealing
how
chronic
viral
impacts
landscape.
We
explore
mechanisms
through
which
can
impact
composition
functionality
cell
populations
induce
shifts
inflammatory
profiles
aging.
Moreover,
we
examine
potential
role
pathologies
such
cardiovascular
diseases,
cancer,
neurodegenerative
disorders,
COVID-19,
Long
COVID.
underlines
importance
understanding
CMV.
It
offers
insights
pathophysiology
age-associated
well
COVID-19
outcomes
among
elderly.
By
unraveling
connections
gain
deeper
aging’s
remarkable
journey
that
infections
play
transforming
system.
Microorganisms,
Год журнала:
2023,
Номер
11(10), С. 2458 - 2458
Опубликована: Сен. 30, 2023
Long
COVID-19
is
a
recognized
entity
that
affects
millions
of
people
worldwide.
Its
broad
clinical
symptoms
include
thrombotic
events,
brain
fog,
myocarditis,
shortness
breath,
fatigue,
muscle
pains,
and
others.
Due
to
the
binding
virus
with
ACE-2
receptors,
expressed
in
many
organs,
it
can
potentially
affect
any
system;
however,
most
often
cardiovascular,
central
nervous,
respiratory,
immune
systems.
Age,
high
body
mass
index,
female
sex,
previous
hospitalization,
smoking
are
some
its
risk
factors.
Despite
great
efforts
define
pathophysiology,
gaps
remain
be
explained.
The
main
mechanisms
described
literature
involve
viral
persistence,
hypercoagulopathy,
dysregulation,
autoimmunity,
hyperinflammation,
or
combination
these.
exact
may
differ
from
system
system,
but
share
same
pathways.
This
review
aims
describe
prevalent
pathophysiological
pathways
explaining
this
syndrome.
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Окт. 24, 2023
The
process
of
aging
is
accompanied
by
a
dynamic
restructuring
the
immune
response,
phenomenon
known
as
immunosenescence.
This
mini-review
navigates
through
complex
landscape
age-associated
changes,
chronic
inflammation,
age-related
autoimmune
tendencies,
and
their
potential
links
with
immunopathology
Long
COVID.
Immunosenescence
serves
an
introductory
departure
point,
elucidating
alterations
in
cell
profiles
functional
dynamics,
changes
T-cell
receptor
signaling,
cytokine
network
dysregulation,
compromised
regulatory
function.
Subsequent
scrutiny
or
“inflammaging,”
highlights
its
roles
susceptibilities
mediator
perturbations
observed
COVID
patients.
introduction
epigenetic
facets
further
amplifies
interconnections.
In
this
compact
review,
we
consider
interactions
between
immunosenescence,
autoimmunity.
We
aim
to
explore
multifaceted
relationships
that
link
these
processes
shed
light
on
underlying
mechanisms
drive
interconnectedness.
With
focus
understanding
immunological
context
aging,
seek
provide
insights
into
how
immunosenescence
inflammation
contribute
emergence
progression
disorders
elderly
may
serve
for
disturbances.
Abstract
Three
and
a
half
years
after
the
pandemic
outbreak,
now
that
WHO
has
formally
declared
emergency
is
over,
COVID-19
still
significant
global
issue.
Here,
we
focus
on
recent
developments
in
genetic
genomic
research
COVID-19,
give
an
outlook
state-of-the-art
therapeutical
approaches,
as
gradually
transitioning
to
endemic
situation.
The
sequencing
characterization
of
rare
alleles
different
populations
made
it
possible
identify
numerous
genes
affect
either
susceptibility
or
severity
disease.
These
findings
provide
beginning
new
avenues
pan-ethnic
therapeutic
well
potential
screening
protocols.
causative
virus,
SARS-CoV-2,
spotlight,
but
novel
threatening
virus
could
appear
anywhere
at
any
time.
Therefore,
continued
vigilance
further
warranted.
We
also
note
emphatically
prevent
future
pandemics
other
world-wide
health
crises,
imperative
capitalize
what
have
learnt
from
COVID-19:
specifically,
regarding
its
origins,
world’s
response,
insufficient
preparedness.
This
requires
unprecedented
international
collaboration
timely
data
sharing
for
coordination
effective
response
rapid
implementation
containment
measures.
Advanced
age
is
one
of
the
significant
risk
determinants
for
coronavirus
disease
2019
(COVID-19)-related
mortality
and
long
COVID
complications.
The
contributing
factors
may
include
age-related
dynamical
remodeling
immune
system,
known
as
immunosenescence
chronic
low-grade
systemic
inflammation.
Both
these
induce
an
inflammatory
milieu
in
aged
brain
drive
changes
microenvironment
neurons
microglia,
which
are
characterized
by
a
general
condition
inflammation,
so-called
neuroinflammation.
Emerging
evidence
reveals
that
privilege
aging
be
compromised.
Resident
cells,
such
astrocytes,
neurons,
oligodendrocytes
but
also
infiltrating
monocytes,
T
cells
macrophages
participate
complex
intercellular
networks
multiple
reciprocal
interactions.
Especially
microglia
playing
regulatory
role
contribute
to
disturbing
homeostasis
impairments
neuroimmune
responses.
Neuroinflammation
trigger
structural
damage,
diminish
regeneration,
neuronal
cell
death,
modulate
synaptic
this
manner
negatively
interfere
with
functions.In
review
article,
we
give
insights
into
interactions
highlight
impact
COVID-19
on
functional
systems
already
modulated
We
discuss
potential
ways
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
proposed
mechanisms
biological
development
persisting
conditions.
summarize
responsible
COVID,
including
autoimmunity,
direct
virus-mediated
cytotoxicity,
hypercoagulation,
mitochondrial
failure,
dysbiosis,
reactivation
other
viruses,
Cytomegalovirus
(CMV).
Finally,
effects
various
interventional
options
can
decrease
propagation
biological,
physiological,
psychosocial
stressors
activation
inhibit
triggering
unbalanced
modulatory
bioactive
nutritional
compounds
along
multimodal
benefits
behavioral
interventions
moderate
exercise,
applied
postinfectious
order
improve
health.
GeroScience,
Год журнала:
2024,
Номер
46(3), С. 2885 - 2899
Опубликована: Фев. 23, 2024
Abstract
The
long
COVID
(coronavirus
disease),
a
multisystemic
condition
following
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
infection,
is
one
of
the
widespread
problems.
Some
its
symptoms
affect
nervous
system
and
resemble
Alzheimer’s
disease
(AD)—a
neurodegenerative
caused
by
accumulation
amyloid
beta
hyperphosphorylation
tau
proteins.
Multiple
studies
have
found
dependence
between
these
two
conditions.
Patients
with
greater
risk
SARS-CoV-2
infection
due
to
increased
levels
angiotensin-converting
enzyme
2
(ACE2),
itself
promotes
generation
which
enhances
AD.
Also,
molecular
pathways
are
alike—misregulations
in
folate-mediated
one-carbon
metabolism,
deficit
Cq10,
disease-associated
microglia.
Medical
imaging
both
diseases
shows
decrease
volume
gray
matter,
global
brain
size
reduction,
hypometabolism
parahippocampal
gyrus,
thalamus,
cingulate
cortex.
In
some
studies,
similar
approach
applied
medication
can
be
seen,
including
use
amino
adamantanes
phenolic
compounds
rosemary.
significance
connections
their
possible
application
medical
practice
still
needs
further
study
but
there
possibility
that
they
will
help
better
understand
COVID.